ArticleThe Biochemical journal2018

Back to the future: new target-validated Rab antibodies for evaluating LRRK2 signalling in cell biology and Parkinson's disease.

Patrick A EyersPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.